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Paediatric treatment costs 
and the HIV epidemic
EAS NELSON, M WEIKERT, JA PHILLIPS 
SUMMARY
As the AIDS epidemic puts additional strains on the 
already overburdened health care systems in sub-Sa­
haran Africa, it becomes more important to estimate the 
cost of the epidemic in terms of health personnel and 
drug treatments. A retrospective review of 250 ran­
domly selected paediatric admissions to a referral hos­
pital in Malawi was undertaken. Groupings of “pos- 
sible/probable AIDS” and “probably not AIDS” were 
used in a comparative analysis of treatment costs. 
Estimated costs of treatments were significantly lower 
than those calculated in a study from Zimbabwe using 
different methodology. Meningitis was the most ex­
pensive condition to treat and accounted for a greater 
percentage of overall cost than either acute respiratory 
infection, diarihoeal disease or measles.
INTRODUCTION
The first adult patient with acquired immune defi­
ciency syndrome (AIDS) was diagnosed in Malawi in 
1985, and the first paediatric patient in 1986.1-2 In 
Malawi, as for most of sub-Saharan Africa, the pre­
dominant mode of HIV transmission is heterosexual,
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with vertical transmission from mother to baby occur­
ring in approximately one quarter of pregnancies. Re­
cent estimates from the Malawi AIDS Control 
Programme are that the HIV seropositive rate in the 
population aged 15 to 49 is 20 pc in urban areas and 8 
pc in rural areas (10 pc overall). However, prevalence 
of HIV infection in infants and children in Malawi is 
not known because the majority of children with sus­
pected HIV infection are not counselled or tested and 
no surveillance surveys have been reported. Counsel­
ling is very time consuming and other more urgent 
nursing and medical duties take precedence over HIV 
testing. There is also anecdotal evidence that as the 
significance of HIV infection becomes better under­
stood, parents arc more likely to refuse HIV testing of 
their child, as a positive result has major implications of 
their own health. Anonymous testing is thus necessary 
to obtain data on paediatric HIV prevalence.
Anonymous HIV testing for surveillance purposes 
has been used in developed countries,3-4 and it is sug­
gested that this information is essential for setting 
public health priorities, for making rational health 
policy, and for implementing and evaluating interven­
tions.3
Existing and increasing poverty in parts of sub- 
Saharan Africa limits access to education and health, 
which hampers and effective response to the epidemic 
and facilitates the spread of HIV. AIDS also targets 
young, sexually active and economically productive 
adults which increases the poverty cycle. In such eco­
nomically deprived communities, the AIDS epidemic 
is stressing overburdened health care systems, which 
are often already unable to provide adequate treatment 
for many potentially curable disease. AIDS patients 
have many hospital, and even in the absence of specific 
antiviral therapies, they consume disproportionate 
amounts of drugs, laboratory tests and personnel time. 
The AIDS epidemic worldwide, and in sub-Saharan
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Africa in particular, will continue to have tremendous 
financial impact on national economies.
This study set out to estimate the cost of drugs and 
personnel for various common categories of paediatric 
disease with particular emphasis on the group of chil­
dren thought to be clinically probably/possibly AIDS.
MATERIALS AND METHODS
It was proposed to undertake anonymous HIV testing 
on a random sample of paediatric admissions and to do 
a comparative analysis of treatment costs in the HIV 
positive and negative groups. However, ethical ap­
proval for anonymous HIV testing was not granted. 
Therefore a retrospective study to assess treatment 
costs was undertaken and, in an attempt to estimate 
treatment costs for AIDS and non-AIDS patients, each 
admission was assigned retrospectively to one of three 
groups: probably AIDS; possibly AIDS; and probably 
not AIDS. Assignment was done independently by two 
paediatricians and clinical experience was the only 
criterion used in assignment.
Two hundred and fifty randomly selected notes of 
admissions to the Paediatric Department of Kamuzu 
Central Hospital (KCH) in Lilongwe from 31st De­
cember 1992 were reviewed. There were 7 386 re­
corded admissions for 1992. Data abstracted from the 
notes included source of referral, dates of birth, admis­
sion and outcome, child’s age and sex, admission 
weight, presenting complaints, outcome, admission 
and discharge diagnoses (up to three) and all drugs 
given and investigations done.
Two hundred and sixteen out of 250 notes were 
located and six of these notes were excluded as they had 
no treatment sheet available. The sample analysed was 
thus 210 (84 pc of intended sample). The admission 
number was randomly selected if the child had been 
admitted more than once. Length of stay (in days) and 
age (in months) were calculated. If the date of birth was 
not reported the recorded age of the child was used.
The presenting complaints and their duration were 
determined by using the notesof the admitting medical 
staff, the referring medical staff and the nursing staff in 
that order of priority. Admission and discharge diag­
noses were coded with International Classification of 
Diseases (ICD) numbers. Admission and discharge 
diagnoses were grouped into nine categories: malaria; 
anaemia; respiratory disease; diarrhoeal disease;
measles; meningitis; malnutrition; surgical; other medi­
cal.
The total number of doses of all medications given 
were abstracted from the treatment sheet. Drugs or­
dered but not reported being given were excluded. 
Blood transfusions and TV fluids were recorded but oral 
rehydration solution, mouth wash solution, vaccines 
and physiotherapy were not recorded. Surgical opera­
tions were difficult to cost and therefore not recorded. 
Investigations were recorded if definitely noted to have 
been taken.
For the purpose of calculating drug costs, the dose 
was estimated as a percentage of the adult dose on the 
basis of weight (first choice) or age (second choice if no 
weight recorded). This method was used rather than 
recording actual doses prescribed to simplify data 
abstraction and analysis. The four weight groups were: 
1 kg to 10kg (25 pc of adult dose); > 10 kg to 20 kg (50 
pc of adult dose); > 20 kg to 30 kg (75 pc of adult dose); 
and > 40kg (adult dose). The corresponding age groups 
were: 0 to 18 months; > 18 to 72 months; > 72 to 144 
months; > 144 months. Drug casts were calculated 
from the Central Medical Store’s price list as shown in 
the following example.
1 000s tablets (250 mg) of Penicillin V « 3  292 tambala (t)
1 tablet (250 mg) of Penicillin V = 3  292/1 0001 
1 adult dose (500 mg) of Penicillin V > 3  292/1 000 x 2 1 
8 doses for a 12 kg child >3292/1000x2x0,5
(50 pc) x 8 t 
> 26,34 t
The cost of investigations were more difficult to 
estimate. Christian Hospitals Association of Malawi 
(CHAM) charge patients for investigations and the 
average cost of the investigations done at three CHAM 
hospitals in the district was used.
Calculation of staff costs was as follows. Ten “one 
week” periods during 1992 were randomly selected 
and the number of staff of each category on the Paediatric 
ward (working or on leave) during each of these periods 
were counted and averaged. This figure of average staff 
was multiplied by the mean annual salary for each 
professional category. All categories were then summed 
to give the total cost of staffper annum. The cost of staff 
per patient per day or bed occupancy day (BOD) was 
calculated by multiplying the total annual admissions 
(n = 7 386) by the average length of stay (7,9 days) for
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the 210 admissions in the study. The total staff cost per 
annum was divided by this figure to give the cost per 
BOD.
Drug costs, investigation costs and staffing cost 
were added to give the total in patient cost. The outpa­
tient cost was calculated as the cost of drugs prescribed 
for home treatment. The total cost o f treatment was the 
sum of the total in patient cost plus the outpatient cost. 
Costs in US$ were calculated using an exchange of 
US$1 = K4,4.
RESULTS
Data from the 210 notes, which were located and had 
treatment sheets, were analysed with Epiinfo 5. The sex 
was documented in 207 cases: 89 (43 pc) females and 
118 (57 pc) males. The average age was 32 months (SD 
± 39, range 1 to 168 months). Admission weights were 
recorded in 183 children (mean weight 8,96 kg; SD ± 
5,78; range 2,2 kg to 30,0 kg). Of the children 83 pc 
were under paediatric medical care and 17 pc were 
under paediatric surgical care. The mean length of 
hospital stay was 7,9 days (SD ± 8,0; range 1 to 61 
days).
Fifty four pc of children had fever; 35 pc cough; 24 
pc diarrhoea; 20 pc swelling; 19pc vomiting; 15 pc pain 
and 15 pc dyspnoea at presentation. There were 34 (16 
pc) deaths, 19 (9 pc) of children who absconded and 
157 (75 pc) children who were discharged home.
Cost of treatm ent: The average cost of treatment in 
Malawi Kwacha (K) were as follows: drugs and inves­
tigations K4.50 (SD ± 5,4); Staff K41,06 (SD ±41,7); 
outpatient drugs at discharge K0,47 (SD ± 1,6); total 
cost of treatment K46.02 (SD ± 44,6) or US$10,5 (see 
Table III). Discharge medications were prescribed for 
68/157 (43 pc) of children discharged home.
Analysis of presentation, diagnosis and cost of 
treatm ent by AIDS group: An AIDS group was 
defined which included those infants (n = 19) which 
both paediatricians assigned to Probable or Possible 
AIDS groups. There were 11 and 12 children thought to 
be probable AIDS by one or other paeditrician but 
probably not AIDS by the other paediatrician. These 23 
children were not included in the AIDS group. Table I 
shows the mean age, weight stay and outcome for the 
AIDS group.
The infants thought to be probable/possible AIDS 
were significantly more likely to present with cough 
(p < 0,01) and diarrhoea (p < 0,0001). Fever, swelling, 
and vomiting as presenting complaints were not sig-
Table I: Outcome, age, weight and stay fo r  children 
assigned to probable/possible and probably not AIDS 
groups (n = 210).
Probable/ 
Possible AIDS 
(n *  19)
Probably 
not AIDS 
(n m 191)
P
Age (months) 16,9 33,3 NS
Weight (kgs) 6,3 9,3 < 0,05 Kruskal-
Wallis
Stay (days) 11.5 7,5 < 0,05 Anova
Outcome Absconded 4,0 15,0 < 0,0001 x2
Died 9,0 25,0
Home 6,0 151,0
Table II: Treatment costs in Malawi Kwacha (K) fo r  
children assigned to probable/possible and probably
not AIDS groups (n = 210).
Probable/ 
Possible AIDS 
(n -1 9 )
Probably 
not AIDS 
(n = 191)
P
Drugs and
investigations K5.14 K 4,43 NS
Staff cost K59.94 K39.18 <0,05*
Outpatient drugs K0.18 K0.50 NS
Total cost K65.26 K44.11 <0,05*
"An ova.
nificantly different between the two groups. Infants 
assigned as probable/possible AIDS were significantly 
more likely to have a discharge diagnosis of malnutri­
tion (p < 0,0001), respiratory disease (p < 0,05) or 
diarrhoeal disease (p < 0,05). There was no significant 
difference in the frequency with which discharge diag­
nose of malaria anaemia measles and meningitis were 
made. Table II shows the cost of treatment for the 
probable/possible AIDS group and the probably not 
AIDS group.
Analysis of cost of treatm ent by diagnostic group: 
Table III shows the cost of treatment of the main 
diagnostic groups in the analysis. Five notes did not 
have discharge diagnoses recorded. Meningitis was the 
most expensive condition to treat in terms of both drugs
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Table III: Costs o f  treatment by first discharge diagnosis (n = 210).
Diagnostic
Category
Mean
Stay
(days)
Inpatient 
drug cost* 
<K)
Staff
cost*
(K)
Outpatient 
drug cost* 
(K)
Total cost* 
(K)/(US$)
Number 
patients 
(n) (pc)
Total cost 
(US$ (pc)
Malaria 4,5 4,33 23,20 0,17 27,7/6,3 39(19) 246(11)
Anaemia 6,4 3,92 33,28 0,02 37,2/8,5 10(5) 85(4)
Respiratory 4,4 2,54 22,88 0,34 25,8/5,9 25 (12) 146(7)
Diarrhoeal 4,1 3,63 21,45 0,18 25,3/5,7 16(8) 92(4)
Measles 6,4 2,99 33,28 0,81 37,1/8,4 10(5) 84(4)
Meningitis 12,5 12,96 65,00 0,42 78,4/17,8 12(6) 214(10)
Malnutrition 12,7 3,91 65,87 0,20 70,0/15,9 21 (10) 334(15)
Surgical 10,8 2,24 55,94 0,45 58,6/13,3 33 (16) 440(20)
Other medical 10,2 6,69 52,80 1.24 60,7/13,8 39(19) 538 (24)
No diagnosis 2,6 2,43 13,52 0,0 16,0/3,6 5(2) 18(1)
All patients 7,9 4,50 41,06 0,47 46,0/10,5 210 2 197(100)
K  »  Malawi Kwacha. *  =  coat par patient
and staff. Also shown is the cost of treating various 
conditions as a percentage of total cost.
DISCUSSION
For the reason stated in the methods, it was not possible 
to obtain the HIV status of the selected admissions. 
This is the major limitation of the study and the com­
parison of costs for the probable/possible AIDS group 
and the probably not AIDS group is thus only an 
approximation. However, the study gives a range of 
costs for treating various common paediatric condi­
tions. The costs calculated are for drugs, medical and 
nursing personnel and investigations -  not included are 
the costs of running the hospital e.g. equipment, main­
tenance, lights, water, administration. While the latter 
costs are of major long term importance they have less 
relevance in the short term. Whether a hospital bed 
contains none, one or two patients the hospital running 
costs are much the same. Even the costs of medical and 
nursing personnel are fixed in the immediate short 
term. Thus the main impact of the AIDS epidemic in the 
short term will be on drug costs and availability and on 
staff morale.
The study shows that those children who are clini­
cally thought to be probable/possible AIDS are more 
expensive to treat than those thought to be probably not
AIDS. Tliis difference in cost is mainly because AIDS 
is suspected clinically in children who stay longer in 
hospital and require numerous treatments i.e. the way 
the probably/possibly AIDS group was selected prede­
termined that they would be more expensive to treat. It 
would be necessary to have actual HIV results to see 
how sensiti ve/specific this clinical assignment of AIDS 
was. The WHO AIDS clinical case definition was not 
used in this study as prospectively collected data would 
have been required.
Other limitations of the study need to be considered. 
Drug costs were based on doses of drugs actually 
signed for. It was noted that often drugs prescribed 
three to four times aday were apparently given only one 
to two times a day. It is possible that on a busy ward, 
drugs may be given but not signed to .  Alternatively 
shortages of drugs or shortages of staff may mean that 
less drugs were given than prescribed. In developing 
countries drugs come in and out of stock and when out 
of stock drugs may be replaced with an alternative or 
with no drug. It is probable that if there were not these 
recurrent shortages, drug costs would be higher than 
those estimated.
Despite the way that the probably/possibly AIDS 
group in our study were selected, their estimated treat­
ment costs were much less than those estimated in a
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study from Zimbabwe. This Zimbabwe study esti­
mated the potential national cost of drugs and staff as a 
result of the AIDS epidemic.6 The study was based on 
methodology developed in Zambia and then applied to 
standard treatment regimes available in Zimbabwe. 
This method of estimating costs differed from our 
method. The cost of drugs was based on the frequency 
with which various diseases are known to occur in 
children with AIDS, and the cost of completely treating 
these diseases. This type of analysis may give a higher 
estimate of treatment costs than those incurred in 
practice. It was estimated that AIDS children in Zimba­
bwe would have an average of 5,12 treatment episodes 
per admission (where one treatment episode= one drug 
used for a full course). The average cost per treatment 
episode was Z$2,35 i.e. an average drug cost per 
admission of Z$12,05 (US$4,21).
Our data suggests that the actual cost of in-patient 
treatment per admission of a patient with clinical AIDS 
was of K5,14 (US$1,17) (Table II). This figure also 
includes investigations done (not included in Zimba­
bwe study). The Zimbabwe study was based on 1990 
prices, whereas our data was based on 1993 prices. 
Although Zimbabwe has more to spend on health per 
capita than Malawi, it is not known whether actual 
costs per admission would be as high as those estimated 
by Jensen.6
The costs of investigation were included in our study 
but there was difficulty deciding on a realistic cost of 
such investigations. The cost of investigations was 
based on what three CHAM hospitals charged patients. 
It is possible that some hospitals subsidise investiga­
tions whereas others “make money” on the investiga­
tions. A number of our patients had an investigation 
repeated but only the cost of one investigation was 
included in the analysis. Furthermore, some investiga­
tions may have been done but not recorded in the notes. 
Thus the cost of investigations may have been underes­
timated.
Staff costs were based on the mean actual salary of 
various categories of staff and the average number of 
staff employed on the ward. This gave a figure of K5,20 
(US$1,18) per patient per day. In the Zimbabwe study 
the average cost per Bed Occupancy Day (BOD) was 
estimated to be Z$55 (US$ 19,25). This calculation was
based on the total “Medica Care Services Budget" 
divided by the total Bed Occupancy days for the whole 
country. Our figure was considerably lower than this. 
Reasons for this discrepancy may include: the Zimba­
bwe study calculation would probably have included 
hospital running costs; it is possible that data on total 
Bed Occupancy Days was underestimated; it is prob­
able that nurses can look after more paediatric patients 
than adult patients and therefore cost per paediatric 
patient is less than the average patient cost.
The Zimbabwe study calculated a nursing cost per 
child per day of Z$1 737 (US$608) by estimating the 
number of episodes of various conditions per patient 
per lifetime and then estimating the nursing days per 
episode. However, in the short term more patients does 
not mean more staff and the actual cost per patient will 
decrease. If the AIDS epidemic were to increase the 
number of admissions by 10 pc it is unlikely that the 
number of nurses/doctors would increase by 10 pc. The 
existing staff would just be expected to look after more 
patients, and patients would be discharged home ear­
lier. In our study the estimated total per annum cost 
(staff and drugs) of treating a child with probable/ 
possible AIDS was US$59,33 (assumes four admis­
sions per year with a cost per admission of US$1,2 for 
in-patient/outpatient drugs and US$13,6 for staff). In 
the Zimbabwe study the equivalent total per annum 
cost of treating a paediatric AIDS patient was US$625 
(four admissions costing US$4,21 per admission on 
drugs and US$608 on nursing care). The discrepancy 
between these figures has important implications for 
health planners.
The second part of the analysis was to look at the cost 
of treating various disease categories. In terms of drug 
costs, meningitis was the most expensive condition to 
treat (K 12,96/US$2,95). Surgical patients were the 
cheapest (K2,24/US$0,51) but the cost of surgery was 
not included in the analysis. Meningitis was also the 
most expensive disease in terms of total cost per patient 
(drug/staff/discharge m edications) at K78,38/ 
US$17,81. As a percentage of overall cost, meningitis 
was the fifth most expensive group of patients to treat 
(10 pc), after general medical (24 pc), surgical (20 pc), 
malnutrition (15 pc) and malaria patients (11 pc) (Table 
III). Meningitis thus appears to be of greater impor­
tance in terms of cost than certain WHO priority 
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diseases (acute respiratory infection, diarrhoeal dis­
ease and measles). This may be a temporary phenom­
enon because Malawi has experienced an outbreak of 
meningococcal meningitis in recent years. However, it 
will be important to review the situation in Malawi and 
elsewhere.
Conclusion: Meningitis cost more to treat than 
certain WHO priority (acute respiratory infection, dis­
ease and measles). This may be related to a recent 
menigococcal outbreak but needs to be examined closer. 
The estimated cost of treating children in Malawi with 
clinical features suggestive of AIDS was US$14,83 per 
admission (in-patient drugs, investigations, staff and 
discharge medicines) or US$59,33 per annum (assum­
ing four admissions per year). This compares to a per 
annum figure of US$625 calculated for Zimbabwe. 
Both calculations show that staff costs are the major 
component of total cost. It is unclear as to what extent 
staffing levels will increase as a result of the AIDS 
epidemic. It is unlikely that existing staff will just be 
expected to care for more and more patients. Drug 
consumption is expected to increase as a result of the 
AIDS epidemic but already many sub-Saharan African 
countries are experiencing continuous shortages of 
essential drugs. The impact of the AIDS epidemic in 
sub-Saharan Africa is thus likely to be less and less 
treatment for all patients -  those with AIDS and those 
without AIDS.
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